Cutaneous Adverse Effects in Patients Treated with BTK Inhibitors.
Simple Summary: Patients treated with BTK inhibitors frequently demonstrate dermatologic toxicities, such as bruising, rash, infections, mucosal symptoms, neutrophilic dermatoses, vasculitis, infections, nail plate abnormalities and hair changes. In most cases, skin toxicities remain mild. Proactive...
| Published in: | Cancers Vol. 18; no. 3; pp. 371 - 389 |
|---|---|
| Main Authors: | , |
| Format: | pictorial review Journal Article |
| Published: |
MDPI
Feb2026
|
| Online Access: | View this record in EBSCOhost |